J.B.D Innovation Ltd., its owner and director Nissim Daniel, Victor Tshuva & Co. – Law Offices, and its owner Victor Tshuva together report beneficial ownership of 543,361 Ordinary Shares of Wearable Devices Ltd., representing 24.82% of the company’s outstanding 2,189,469 Ordinary Shares as of June 17, 2026.
J.B.D holds 477,361 shares (about 21.80%) and Victor Tshuva & Co. holds 66,000 shares (about 3.01%), for a total investment of approximately $951,425. On July 27, 2026, they sent a demand letter requesting a special general meeting to amend Articles provisions on director elections and removals, remove certain incumbent directors, elect four nominees they propose, and approve related compensation, exemption, indemnification, and insurance arrangements. J.B.D and Victor Tshuva & Co. agreed to act in concert regarding these shares and to transfer 66,000 shares to Victor Tshuva & Co. at $1.751 per share, while all parties expressly disclaim being part of a statutory group beyond their pecuniary interests.
Wearable Devices Ltd. is implementing a 1-for-3 reverse share split of its ordinary shares and publicly traded warrants to support continued listing on the Nasdaq Capital Market. Every three ordinary shares and three warrants will be consolidated into one share and one warrant, with warrant exercise prices adjusted proportionately.
After the reverse split, issued and outstanding ordinary shares will decrease from 6,568,408 to approximately 2,189,469, and publicly held warrants from 32,886 to approximately 10,962, while authorized share capital remains 500,000,000 ordinary shares. The shares and warrants will begin trading on a split-adjusted basis on June 22, 2026 under the existing symbols WLDS and WLDSW.
The company states that the primary goal is to increase its share price to regain compliance with Nasdaq’s $1.00 minimum bid price requirement and to help protect its continued listing status under updated Nasdaq rules.
Wearable Devices Ltd. reported the results of its Special General Meeting of Shareholders held on June 4, 2026. The meeting was initially convened at 11:00 a.m. Israel time but adjourned due to lack of quorum and reconvened at 12:30 p.m., when a quorum was present. Shareholders then approved, by the requisite majority, the single proposal described in the company’s previously distributed Notice and Proxy Statement. This report and its exhibits are also incorporated by reference into the company’s existing registration statements on Form S-8 and Form F-3.
Wearable Devices Ltd. filed a Form 6-K highlighting a press release that opens pre-orders for its new Mudra Pro device for qualified enterprise and OEM customers. Mudra Pro is a thinner, ergonomic wrist band that combines electromyography and inertial sensors with a new photoplethysmography sensor to capture muscle, motion, and cardiovascular signals.
The product is aimed at original equipment manufacturers, enterprise innovation teams, researchers, and developers, giving them access to specifications, a software development kit, and pilot-oriented resources. It is part of the company’s ai6 Labs initiative to advance AI-native neural sensing and intent-based user interfaces for AI and extended reality applications.
Wearable Devices Ltd. has called a special shareholder meeting to vote on a potential reverse split of its ordinary shares at a ratio of up to 4:1. The board would have discretion over whether to implement the split, the exact ratio and the effective date.
The company says the reverse split is intended to support continued listing of its shares on Nasdaq and make the stock more attractive to a broader range of investors. The move would reduce the number of issued and outstanding shares, while leaving authorized capital at 500,000,000 ordinary shares.
The meeting is scheduled for June 4, 2026, with shareholders of record as of May 21, 2026 entitled to vote. A quorum requires holders of at least 25% of outstanding ordinary shares, and approval needs a simple majority of votes cast.
Wearable Devices Ltd. ownership disclosure: Armistice Capital, LLC and Steven Boyd report beneficial ownership of 230,752 ordinary shares, representing 8.00% of the class. The holdings are held by Armistice Capital Master Fund Ltd., for which Armistice Capital acts as investment manager; the Master Fund disclaims beneficial ownership under its Investment Management Agreement.
The filing is a joint Schedule 13G/A amendment signed May 15, 2026, reporting shared voting and dispositive power over the 230,752 shares.
Wearable Devices Ltd. Chief Marketing Officer Barel Shmuel reported an open-market sale of 7,182 Ordinary Shares of the company on May 12, 2026 at $1.00 per share. After this transaction, he continues to hold 24,151 Ordinary Shares directly.
Wearable Devices Ltd. filed a Form 6-K to furnish a press release announcing Mudra Pro, a next-generation wearable neural sensing wristband aimed at advanced AI, XR, and human-machine interaction applications. The device targets product managers, developers, researchers, enterprise innovation teams, OEMs, and technology partners.
Mudra Pro integrates synchronized electromyography (EMG), photoplethysmography (PPG), and inertial measurement unit (IMU) sensors, combined with an ARM Cortex-M33 processor and Bluetooth Low Energy communication, to decode human intent and physiological state. Paired with Mudra Studio and developed within the company’s ai6 Labs initiative, it is intended to support natural interaction, rapid prototyping, and data analytics for spatial computing. The filing also includes a detailed forward-looking statements disclaimer.
Wearable Devices Ltd. entered a warrant inducement transaction with an institutional investor, raising approximately $5.0 million in gross cash proceeds through the cash exercise of existing warrants at a reduced price of $1.73 per ordinary share.
In return, the company issued new unregistered warrants to purchase up to 5,082,873 ordinary shares at an exercise price of $1.51 per share, exercisable immediately for five years. The company plans to use the net proceeds for working capital and general corporate purposes and agreed to register the resale of the new warrant shares and observe a 30‑day restriction on additional issuances, new registrations, and variable rate transactions, subject to stated exceptions.
Wearable Devices Ltd. director Bachar Eli filed an initial ownership report showing direct holdings in both ordinary shares and stock options. He reports 37,884 Ordinary Shares held directly, plus stock options over 768 Ordinary Shares at an exercise price of $0.7200 per share expiring on November 27, 2027, and options over 83 Ordinary Shares at an exercise price of $316.8000 per share expiring on November 30, 2033. Footnotes indicate additional equity incentives, including 7,500 Ordinary Shares issuable from 2,500 restricted share units vesting through October 10, 2028, and 28,333 Ordinary Shares issuable from other restricted share units vesting in 34 monthly installments through January 1, 2029.